Comparison

HTT-D3 European Partner

Item no. HY-143792-1ea
Manufacturer MedChem Express
CASRN 2254502-89-9
Amount 1 ea
Quantity options 100 mg 1 ea
Category
Type Chemicals
Specific against other
Formula C23H25FN6
Citations [1]Anuradha Bhattacharyya, et al. Small molecule splicing modifiers with systemic HTT-lowering activity. Nat Commun. 2021 Dec 15;12(1):7299.
Smiles FC1=CC(C2=NN3C(C(C)=C2)=NC(C)=C3)=CC4=NN=C(C5CCN(CC)CC5)C=C14
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Product Description
HTT-D3 is a potent and orally active huntingtin (HTT) splicing modulator. HTT-D3 acts by promoting the inclusion of a pseudoexon containing a premature termination codon (stop-codon psiExon), leading to HTT mRNA degradation and reduction of HTT levels. HTT-D3 reduces p-glycoprotein (P-gp) efflux, and can be uesd for Huntington's disease research[1].
Shipping
Room temperature
Manufacturers Applications
Neuroscience-Neurodegeneration
MolecularWeight
404.48
Clinical Information
No Development Reported
Manufacturers Research Area
Neurological Disease
Solubility
10 mM in DMSO
Target
P-glycoprotein
Manufacturers Target
P-glycoprotein
Manufacturers Pathway
Membrane Transporter/Ion Channel
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close